StockNews.com Begins Coverage on Bio-Path (NASDAQ:BPTH)

StockNews.com assumed coverage on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a research report report published on Wednesday. The brokerage issued a sell rating on the stock. Bio-Path Stock Performance Shares of BPTH stock opened at $0.49 on Wednesday. Bio-Path has a 52-week low of $0.32 and a 52-week high of $2.35. The firm […]

Related Keywords

United States , ,Path Holdings Inc ,Virtu Financial ,Renaissance Technologies ,Path Company Profile ,Walleye Capital ,Citadel Advisors ,Free Report ,Get Free Report ,Path Holdings ,Bio Path Daily ,Bio Path ,Nasdaq Bpth ,Bpth ,Medical ,Initiated Coverage ,Stocknews Com ,